Navigation Links
ShengdaTech to Present at Rodman & Renshaw Annual China Investment Conference in Shanghai
Date:2/28/2011

SHANGHAI, Feb. 28, 2011 /PRNewswire-Asia-FirstCall/ -- ShengdaTech, Inc. ("ShengdaTech" or the "Company") (NASDAQ: SDTH), a leading manufacturer of nano-precipitated calcium carbonate ("NPCC") in China, today announced that Mr. Xiangzhi Chen, the Company's chairman and CEO, Ms. Anhui Guo, COO and acting CFO and Mr. A. Carl Mudd, lead independent director, will attend the Rodman & Renshaw Annual China Investment Conference to be held from March 6-8, 2011 in Shanghai.

The date, time, and location of ShengdaTech's presentation at the Conference are as follows:Date:Tuesday, March 8, 2011Time:  

11:30 a.m. Presenter:

Crocker Coulson, President of CCG Investor RelationsLocation:  

Ballroom II, Le Royal Meridien, Shanghai, ChinaA copy of ShengdaTech's investor presentation will be made available online at: http://www.shengdatechinc.com on the day it is presented.

The Rodman & Renshaw's 2011 Annual China Investment Conference will feature diverse industry sectors, including Agriculture, Automotive, Cleantech & Energy, Consumer, Education, Healthcare, Industrial, Metals & Mining, and Technology. The conference is expected to attract over 150 public and private companies and more than 1,000 attendees. For more information about the conference and registration, please visit www.rodm.com/conferences.  

Investors who wish to meet with ShengdaTech's management may contact Rodman & Renshaw or ShengdaTech's IR representative in the U.S., Roger Ellis at +1 (310) 954 1332 or roger.ellis@ccgir.com.

About ShengdaTech, Inc.  ShengdaTech is engaged in the business of manufacturing, marketing, and selling nano-precipitated calcium carbonate ("NPCC") products. The Company converts limestone into NPCC using its proprietary and patent-protected technology. NPCC products are increasingly used in tires, paper, paints, building materials, and other chemical products. In addition to its broad customer base in China, the Company currently exports to Singapore, Thailand, South Korea, Malaysia, India and Latvia. For more information, contact CCG Investor Relations directly or go to ShengdaTech's website at http://www.shengdatechinc.com.

Contact:Anhui Guo, Chief Operating OfficerShengdaTech, Inc.gah@shengdatech.com www.shengdatechinc.comCCG Investor RelationsCrocker Coulson, PresidentTel:   +1-646-213-1915 (NY office)Email: crocker.coulson@ccgir.com www.ccgirasia.comElaine Ketchmere, PartnerTel:   +1-310-954-1345 (LA office)Email: elaine.ketchmere@ccgir.com
'/>"/>

SOURCE ShengdaTech, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. InterMune to Present at Canaccord Adams Conference
2. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2008
3. Verenium Corporation to Present at Canaccord Adams 28th Annual Global Growth Conference
4. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CANACCORD ADAMS 28TH ANNUAL GLOBAL GROWTH CONFERENCE
5. Bionovo to Present at Canaccord Adams Global Growth Conference
6. Pharmasset to Present at the Canaccord Adams Global Growth Conference on Tuesday, August 12th
7. VIA Pharmaceuticals to Present at Fourth Annual Noble Financial Equity Conference
8. Access Pharmaceuticals to Present at the Noble Financial Equity Conference
9. Bluestar Silicones Presents Adhesive Gels for Wound Care at Medical Grade Polymers Conference
10. Duska Therapeutics to Present at Noble Financial Equity M.A.D. MAX Conference on Tuesday, August 19th at 1:30 p.m. PDT
11. Cepheid to Webcast Upcoming Financial Presentations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 2017  BioPharmX Corporation (NYSE MKT: BPMX), a ... market, today reported financial results for the quarter ... provide an update on the company,s clinical development ... "We are pleased to report that last year ... President Anja Krammer. "We achieved key clinical milestones ...
(Date:3/23/2017)... Kineta, Inc., a biotechnology company focused ... immuno-oncology, today announced the discovery and characterization of ... activate interferon response factor 3 (IRF3) via RIG-I ... regression in a murine colon carcinoma mouse model.  ... tumor regression to initial drug treatment were resistant ...
(Date:3/23/2017)... 2017 According to a report by Transparency ... fragmented due to the presence of a large pool of participants; ... Fisher , and Sigma-Aldrich, compete with each other in this market. ... more than 76% of this market in 2016.  ... As of now, a large number ...
(Date:3/23/2017)... 23, 2017 In today,s pre-market ... in the Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), ... MKT: SYN), and Regulus Therapeutics Inc. (NASDAQ: ... Credit Suisse upgraded its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." ... report at: ...
Breaking Biology Technology:
(Date:2/22/2017)... , Feb. 22, 2017 With ... 2021, ABI Research identifies four technologies that innovative ... to secure significant share in the changing competitive ... and passive authentication.   "Companies can ... comes to security," says Dimitrios Pavlakis , ...
(Date:2/13/2017)... 2017  RSA Conference -- RSA, a Dell Technologies ... to enhance fraud detection and investigation across digital ... Fraud & Risk Intelligence Suite. The new platform ... insights from internal and external sources as well ... customers from targeted cybercrime attacks. "Fraudsters ...
(Date:2/8/2017)... 7, 2017  Aware, Inc. (NASDAQ: AWRE ), ... financial results for its quarter and year ended December 31, ... 2016 was $3.9 million compared to $6.9 million in the ... of 2016 was $0.6 million compared to $2.6 million in ... quarter of 2016 was $0.5 million, or $0.02 per diluted ...
Breaking Biology News(10 mins):